Equities

Positron Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
POSC:PKC

Positron Corp

Actions
  • Price (USD)1.78
  • Today's Change0.12 / 7.23%
  • Shares traded11.15k
  • 1 Year change-7.77%
  • Beta0.7837
Data delayed at least 15 minutes, as of Feb 06 2026 20:22 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Positron Corporation is a medical technology company focused to advancing the Positron Emission Tomography (PET) imaging modality through the development, manufacturing, and commercialization of its PET and PET-CT (Positron Emission Tomography/Computed Tomography) imaging systems along with providing comprehensive clinical services to nuclear medicine healthcare providers across North America. The Company specializes in the field of cardiac PET imaging, the gold standard in cardiac diagnostics. The Company’s imaging portfolio includes dedicated PET and 3D PET-CT 64-Slice systems, both designed to expand access to advanced molecular imaging. Additionally, it is preparing to introduce its 4D PET-CT 64-Slice scanner in nuclear cardiology. Its products, Attrius PET and NeuSight PET-CT 64- Slice scanner, provide a molecular imaging solution, enabling healthcare providers with diagnostic accuracy for cardiac and oncologic applications.

  • Revenue in USD (TTM)1.24m
  • Net income in USD-1.27m
  • Incorporated2014
  • Employees22.00
  • Location
    Positron Corp1777 Maryland AveNIAGARA FALLS 14305United StatesUSA
  • Phone+1 (317) 813-0673
  • Fax+1 (845) 818-3588
  • Websitehttps://www.positron.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cytosorbents Corp34.35m-10.59m42.20m149.00--4.68--1.23-0.19-0.190.560.14360.73442.184.89230,553.30-22.63-34.58-28.22-41.8077.0270.00-30.81-62.081.71--0.6176--14.517.3729.16---15.13--
Precision Optics Corporation Inc21.58m-6.11m43.54m90.00--3.98--2.02-0.8505-0.85053.011.421.095.005.90239,722.70-30.82-13.63-45.79-19.5114.9929.56-28.30-11.580.785-28.850.1375---0.068513.98-95.85--7.81--
electroCore, Inc.29.84m-14.16m43.58m73.00------1.46-1.70-1.703.59-0.14051.412.6329.39408,698.60-66.70-65.38-126.40-87.8786.0480.72-47.46-159.341.33--1.20--57.0960.1536.89------
Neuraxis Inc3.36m-8.37m46.34m21.00--18.85--13.78-1.02-1.020.40590.23110.97187.9441.74160,111.00-217.93---1,360.57--84.34---224.24--1.55-97.220.0789--9.18--42.21------
Spectral AI Inc23.17m-16.37m46.65m78.00------2.01-0.7206-0.72060.9706-0.3011.7228.4112.12297,025.70-121.66------45.01---70.64--0.8252-11.99----63.83--26.56------
Sharps Technology Inc2.51m-104.37m47.84m5.00--0.1052--19.05-690.20-690.200.395715.680.0111.81--502,354.00-45.86-86.10-47.44-125.430.1489---4,155.30--3.67--0.0173------5.54--65.50--
Heartbeam Inc0.00-20.62m49.25m16.00--120.95-----0.6638-0.66380.000.01180.00----0.00-432.60-142.55-792.01-190.45------------0.00-------32.85------
Alpha Pro Tech Ltd59.10m3.68m51.39m130.0014.530.815711.410.86950.34150.34155.466.080.8031.6410.62454,584.605.0013.855.2314.5838.2140.646.2312.787.70--0.000.00-5.544.39-6.215.5424.04--
Nutriband Inc2.28m-34.59m52.96m13.00--7.01--23.25-3.07-3.070.20030.6210.21749.9617.72---121.91-66.47-134.92-78.0433.5037.16-560.85-340.947.35--0.022--2.6041.99-91.10------
Positron Corp1.24m-1.27m55.90m22.00------45.19-0.0897-0.08970.0876-0.11090.59762.296.56---61.35-224.13----32.989.85-102.67-201.870.0638-------10.060.275163.63--4.36--
Medinotec Inc11.43m2.34m58.78m51.0025.0810.6924.695.140.19940.19940.97340.46791.874.047.03224,166.5038.33--49.87--58.25--20.48--3.8937.940.00008--81.53--633.61------
CS Diagnostics Corp0.00-341.62k59.50m5.00---------531,454.00-531,454.00----0.00-------579.61-1,264.84-----------209,220.50------------32.83------
QT Imaging Holdings Inc11.50m-19.51m59.63m20.00------5.19-2.09-2.091.27-0.9391.201.346.57574,821.50-204.52---4,313.85--50.81---169.73--0.4745-2.0280.26--11,987.88---132.34------
Pulmonx Corp91.66m-56.75m61.87m291.00--1.03--0.675-1.41-1.412.281.460.59971.477.20314,996.60-37.13-26.27-42.91-28.9673.3072.91-61.91-89.484.15--0.3821--22.0120.787.31--14.98--
Forian Inc28.11m-852.58k64.94m1.00--2.08--2.31-0.0274-0.02740.90241.000.5692--4.4628,106,910.00-1.73-24.90-2.92-29.2355.4071.84-3.03-67.83----0.00---5.015.68-257.42------
DarioHealth Corp24.73m-37.11m67.25m196.00--0.8987--2.72-12.47-12.478.2911.070.21732.226.51126,183.70-37.17-63.89-42.41-75.3056.8634.31-171.09-262.344.02-69.690.2901--32.8629.0435.47--7.09--
Data as of Feb 06 2026. Currency figures normalised to Positron Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.